Sharp Therapeutics Corp. (TSXV:SHRX)
Canada flag Canada · Delayed Price · Currency is CAD
0.9100
-0.0900 (-9.00%)
At close: Jun 30, 2026

Sharp Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.

Assets

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
0.963.480.380.110.06
Cash & Short-Term Investments
0.963.480.380.110.06
Cash Growth
-72.55%824.64%241.15%75.59%-
Accounts Receivable
---0-
Other Current Assets
0.060.030.050.01-
Total Current Assets
1.023.520.430.130.06
Net Property, Plant & Equipment
0.921.021.1--
Other Long-Term Assets
0.020.020.02--
Total Assets
1.954.551.550.130.06

Liabilities

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
0.850.520.410.030.01
Current Portion of Long-Term Debt
--5.89--
Current Portion of Leases
0.110.040.03--
Unearned Revenue
----0.06
Other Current Liabilities
--1.39--
Total Current Liabilities
0.950.697.720.030.07
Long-Term Debt
--1.19--
Long-Term Leases
1.171.281.32--
Other Long-Term Liabilities
-0.132.81--
Total Long-Term Liabilities
1.171.415.31--
Total Liabilities
2.131.9713.030.030.07

Shareholders' Equity

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
2521.794.550.12-
Additional Paid-in Capital
0.920.670.59--
Accumulated Other Comprehensive Income
-0.040.01---
Retained Earnings
-26.06-19.89-16.62-0.03-0.01
Shareholders' Equity
-0.182.58-11.480.09-0.01
Total Liabilities & Equity
1.954.551.550.130.06

Additional Metrics

Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
1.281.328.4200
Net Cash (Debt)
-0.332.17-8.040.110.06
Net Cash Growth
---75.59%-
Net Cash Per Share
-0.010.24-1.851.39-
Book Value
-0.182.58-11.480.09-0.01
Book Value Per Share
-0.010.29-2.641.14-
Tangible Book Value
-0.182.58-11.480.09-0.01
Tangible Book Value Per Share
-0.010.29-2.641.14-